Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 6.91 USD 0.14% Market Closed
Market Cap: 889.2m USD

Relative Value

The Relative Value of one NEO stock under the Base Case scenario is 20.99 USD. Compared to the current market price of 6.91 USD, Neogenomics Inc is Undervalued by 67%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NEO Relative Value
Base Case
20.99 USD
Undervaluation 67%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
69
Median 3Y
2.9
Median 5Y
3.5
Industry
4
Forward
1.2
vs History
vs Industry
100
Median 3Y
-17.8
Median 5Y
-18.2
Industry
31.4
Forward
43
vs History
41
vs Industry
1
Median 3Y
-17.3
Median 5Y
-17.2
Industry
19.5
vs History
vs Industry
Median 3Y
-30.5
Median 5Y
-15.8
Industry
33.5
vs History
95
vs Industry
62
Median 3Y
1.9
Median 5Y
2.2
Industry
2.7
vs History
98
vs Industry
68
Median 3Y
3.1
Median 5Y
3.7
Industry
3.8
Forward
1.2
vs History
98
vs Industry
67
Median 3Y
7.6
Median 5Y
8.9
Industry
8.4
vs History
vs Industry
4
Median 3Y
-70
Median 5Y
-43.9
Industry
17.5
Forward
15.5
vs History
vs Industry
Median 3Y
-17.9
Median 5Y
-20.5
Industry
23.6
Forward
-11.2
vs History
41
vs Industry
1
Median 3Y
-18.2
Median 5Y
-18.2
Industry
18.1
vs History
vs Industry
Median 3Y
-34.3
Median 5Y
-51.4
Industry
23.5
vs History
98
vs Industry
66
Median 3Y
1.5
Median 5Y
1.7
Industry
2.4

Multiples Across Competitors

NEO Competitors Multiples
Neogenomics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Neogenomics Inc
NASDAQ:NEO
886.9m USD 1.3 -11.4 -66.4 -10.2
US
PerkinElmer Inc
LSE:0KHE
1T USD 375.7 3 631.2 1 273.2 2 597
US
Thermo Fisher Scientific Inc
NYSE:TMO
157.2B USD 3.7 24.1 16.9 23.3
US
Danaher Corp
NYSE:DHR
138.3B USD 5.8 36.7 20.3 29.5
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.5 55.6 32.3 44.9
CH
Lonza Group AG
SIX:LONN
39.8B CHF 6.1 62.4 22.9 35.8
CN
WuXi AppTec Co Ltd
SSE:603259
227.6B CNY 5.6 20.4 19.7 19.7
US
Agilent Technologies Inc
NYSE:A
32.2B USD 4.9 27.6 18.8 22.1
US
IQVIA Holdings Inc
NYSE:IQV
27.6B USD 1.8 20.7 11.5 17.1
US
Mettler-Toledo International Inc
NYSE:MTD
24.6B USD 6.4 29 21.5 23.9
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.9B EUR 6.6 92 29.6 52.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Neogenomics Inc
NASDAQ:NEO
Average EV/EBITDA: 146.7
Negative Multiple: -66.4
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 273.2
7%
181.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
16.9
6%
2.8
US
Danaher Corp
NYSE:DHR
20.3
7%
2.9
KR
Samsung Biologics Co Ltd
KRX:207940
32.3
17%
1.9
CH
Lonza Group AG
SIX:LONN
22.9
18%
1.3
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
24%
0.8
US
Agilent Technologies Inc
NYSE:A
18.8
10%
1.9
US
IQVIA Holdings Inc
NYSE:IQV
11.5
9%
1.3
US
Mettler-Toledo International Inc
NYSE:MTD
21.5
4%
5.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
29.6
20%
1.5